CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
Zapata Quantum Partners with QuEra to Advance the Commercial Viability of Quantum Applications
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
Marex Group Limited announces second quarter 2026 results
WhiteFiber, Inc. Reports Second Quarter 2026 Results
Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
Aurora Mobiles Modellix Adds PixVerse V6: Finished-Grade Video in One Request
Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates
SU Group Holdings Fortune Jet to Expand Security Training and Advisory Services Across Greater China
Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights
FirstService Residential Expands in Southern Delaware, Welcoming Sea Colony East Phase III Condominium to Its Premier Portfolio
Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder
Performance Food Group Company Reports Fourth-Quarter and Full-Year Fiscal 2026 Results
Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights